Efficacy and Safety of Enteric-coated Mycophenolate Sodium in Heart Transplant Recipients
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
18 Years to 65 Years (Adult)
Sexes Eligible for Study:
Patients who were participating in the core study CERL080A2401 and have successfully completed the first 12 months of the core study
Patients who did not complete the 12-month core study CERL080A2401
Other protocol-defined inclusion/exclusion criteria may apply.